Forge Therapeutics, Inc. is an early stage biotechnology company discovering and developing novel therapeutics using an innovative chemistry platform targeting metalloproteins. Their initial focus is on the discovery of new antibacterial therapeutics where a significant need exists due to the emergence of drug resistant strains of bacteria.
Area of focus: Therapeutics/Infectious disease, Oncology, Platform technology
Commencement date: April, 2015
Location: JLABS @ San Diego